prostate cancer
99 projects
HEIndividual fellowship2027–2028Austria
GlycoIMPACT · Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies
2 partners · 2 countries
HEIndividual fellowship2026–2028Finland
MarkovForScreening · Risk-Stratified and Personalized Cancer Screening with Bidirectional Multistate Markov Models
2 partners · 2 countries
HEIndividual fellowship2026–2028United Kingdom
PREDiCT-AI · AI-Driven Drug Discovery: Pancreatic Cancer Resistance via ENT1 Differential Conformation Tracking
2 partners · 2 countries
HEIndividual fellowship2026–2028Switzerland
TRACE · Tunable Radiolabelled Agents based on Molecular Cages for Theranostics
HEIndividual fellowship2026–2028United Kingdom
eN-TIME · Unravel the role of extracellular NNMT (eNNMT) in the modulation of prostate cancer (PC) tumor immune microenvironment (TIME)
2 partners · 2 countries
HEIndividual fellowship2026–2028Spain
DiscoverableTumor · Oncogene-driven immunosuppression via glyco-immune checkpoint modulation in pancreatic ductal adenocarcinoma.
HEIndividual fellowship2025–2027United Kingdom
GlycoPDAC · Unraveling the role of O-glycosylation in pancreatic ductal adenocarcinoma.
HEIndividual fellowship2025–2027Belgium
noCOLDmore · Reprogramming eNdOthelial cells in immune-COLD tuMORs
2 partners · 2 countries
HEDoctoral network2024–2028Netherlands
Mac4Me · Macrophage Targets for Metastatic Treatment
26 partners · 13 countries
HEIndividual fellowship2024–2026Germany
EVO-PDAC · Evolutionary dynamics of pancreatic cancer at single-cell and spatial levels
HEIndividual fellowship2024–2025Spain
NIR-NanoCAR · Near-Infrared Photothermal Nano-CAR Immunotherapy mediated by engineered exosomes targeted to pancreatic cancer with mutated KRAS
2 partners · 2 countries
HEIndividual fellowship2024–2025Belgium
ORIBAR · Defining the origin of Barrett’s oesophagus by exploring a submucosal gland stem cell model
HEDoctoral network2024–2028Netherlands
PRESSURE · Preventing Therapy Resistance in Esophageal Cancer Using Advanced Models and Molecular Signatures
21 partners · 9 countries
HEIndividual fellowship2023–2025Portugal
TRAIN · Tumor Regulation Assisted by Immunity and Nanotechnology
H2020Individual fellowship2022–2024France
METACIL · Unveiling the molecular interplay between primary cilia and metabolism in cancer
H2020Individual fellowship2022–2024Spain
Onco-inflammation · Origin of genomic instability: Understanding the biological influence of inflammation in the initiation of pancreatic tumorigenesis
H2020Individual fellowship2021–2023Italy
METAREPAIR · INVESTIGATING THE IMPACT OF NUTRITIONAL METABOLISM ON DNA DAMAGE REPAIR IN CANCER
H2020Individual fellowship2021–2023Switzerland
NERVASION · Targeting microenvironment of cancer-invaded-nerves in pancreatic adenocarcinoma.
H2020Individual fellowship2021–2022Netherlands
OCIC · Ongoing chromosomal instability in cancer: real-time imaging and single cell genetics of missegregating chromosomes.
H2020Individual fellowship2021–2026France
tZR-CA-InVivo · Targeted contrast agents to better detect pancreatic tunor and its zinc content by MRI on mice
H2020Individual fellowship2021–2023United Kingdom
PSIPCancer · Role of PSIP1 in prostate cancer development and drug resistance
H2020Individual fellowship2021–2023Germany
SCEPTRE · Single Cell EPigenomic, Transcriptomic, and structural Rearrangement profiling to investigate Evolution in prostate cancer
H2020Individual fellowship2021–2023France
MANTARGET · Super resolution imaging of nanoPMOs for cancer drug delivery
H2020Individual fellowship2021–2022Finland